Literature DB >> 21747076

Fulminant cerebral demyelination in neuromyelitis optica.

Christopher R Newey1, Robert A Bermel.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21747076     DOI： 10.1212/WNL.0b013e3182242d6e

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Devastating aquaporin-4 and HTLV-1-associated necrotizing encephalopathy.

Authors:  Mkael Symmonds; Niranjanan Nirmalananthan; Graham P Taylor; Leslie R Bridges; Frederick Schon
Journal:  J Neurol       Date:  2012-08-24       Impact factor: 4.849

Review 3.  What do we know about brain contrast enhancement patterns in neuromyelitis optica?

Authors:  Yeliz Pekcevik; Gunes Orman; In Ho Lee; Maureen A Mealy; Michael Levy; Izlem Izbudak
Journal:  Clin Imaging       Date:  2015-07-26       Impact factor: 1.605

Review 4.  Molecular pathogenesis of neuromyelitis optica.

Authors:  Wajih Bukhari; Michael H Barnett; Kerri Prain; Simon A Broadley
Journal:  Int J Mol Sci       Date:  2012-10-11       Impact factor: 5.923

Review 5.  Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Authors:  Sarosh R Irani; Jeffrey M Gelfand; Adam Al-Diwani; Angela Vincent
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.